Fasting and Ketogenic Diets: Reducing Th17 Neutrophil Expression and Enhancing Treg Activity in Gut Autoimmunity

Autoimmune diseases, particularly those affecting the gut such as Crohn’s disease, ulcerative colitis, and celiac disease, are characterized by chronic inflammation and dysregulation of the immune system. A growing body of research has identified the critical roles of T helper 17 (Th17) cells and regulatory T cells (Tregs) in these autoimmune conditions. Th17 cells are potent drivers of inflammation, while Tregs play a crucial role in immune tolerance and preventing autoimmunity. Managing the balance between these immune cell populations is essential for reducing inflammation and improving outcomes in autoimmune diseases. Recent studies suggest that fasting and ketogenic dietary interventions may provide significant benefits in modulating Th17 and Treg expression, particularly in gut-related autoimmune diseases.

The Role of Th17 and Tregs in Autoimmunity

Th17 cells are a subset of pro-inflammatory T helper cells that produce interleukin-17 (IL-17), a cytokine that drives the recruitment and activation of neutrophils. These cells are involved in the defense against extracellular pathogens but can also contribute to autoimmune pathology when dysregulated. In gut-related autoimmune diseases, Th17 cells exacerbate inflammation by promoting neutrophil infiltration and activation, which can lead to tissue damage and worsen disease progression .

On the other hand, Tregs are crucial for maintaining immune homeostasis and preventing autoimmunity. These cells suppress excessive immune responses, including the activity of Th17 cells, and promote tolerance to self-antigens . The balance between Th17 and Treg cells is essential for immune regulation, and a shift towards Th17 dominance is a hallmark of many autoimmune diseases, including those affecting the gut.

The Positive Impact of Fasting on Th17 and Treg Modulation

Fasting, whether intermittent or prolonged, has been shown to have profound effects on immune modulation, particularly in reducing Th17 activity and promoting Treg function. During fasting, the body shifts its metabolism from glucose to fatty acids and ketones, which has several downstream effects on immune function.

Research indicates that fasting reduces the differentiation and expansion of Th17 cells. This is primarily mediated by the reduction of inflammatory cytokines such as IL-6 and IL-23, which are critical for Th17 differentiation . Additionally, fasting increases the expression of Tregs, promoting an anti-inflammatory environment. This shift from Th17 dominance to Treg activity can help ameliorate the chronic inflammation seen in gut-related autoimmune conditions .

In animal models of multiple sclerosis (an autoimmune disease with a significant Th17 component), fasting-mimicking diets have been shown to reduce Th17-driven inflammation and increase Treg activity, resulting in improved clinical outcomes . While these findings are specific to multiple sclerosis, similar mechanisms are likely at play in gut autoimmunity, where Th17 cells and neutrophils drive inflammation.

The Ketogenic Diet and Its Impact on Th17/Treg Balance

The ketogenic diet, a high-fat, low-carbohydrate diet that induces a state of ketosis, has gained attention for its anti-inflammatory and immune-modulating effects. Ketosis promotes the production of ketone bodies, such as beta-hydroxybutyrate (BHB), which have been shown to have direct effects on immune cells.

Studies have demonstrated that BHB inhibits the activation of the NLRP3 inflammasome, a key driver of inflammatory cytokine production . This inhibition reduces the levels of IL-1β and IL-6, both of which are critical for Th17 cell differentiation. By lowering the availability of these cytokines, the ketogenic diet reduces Th17 cell expansion and activity.

Moreover, the ketogenic diet has been shown to increase the number and function of Tregs. This may be due to the anti-inflammatory environment created by the reduction of glucose and insulin levels, both of which can promote inflammation . In gut-related autoimmune diseases, where excessive Th17 activity leads to neutrophil infiltration and tissue damage, the ketogenic diet offers a promising strategy for reducing inflammation and promoting immune regulation through enhanced Treg activity.

Managing Fasting and Ketogenic Diets with Organic Acid Testing and Anti-Cardiolipin Analysis

While both fasting and ketogenic diets offer potential benefits for managing autoimmune diseases, it is important to monitor the body’s response to these interventions. Two useful testing modalities for assessing the effectiveness of these dietary interventions are organic acid testing and anti-cardiolipin blood marker serum analysis.

Organic Acid Testing

Organic acid testing is a comprehensive metabolic analysis that can provide insights into how well the body is processing nutrients, producing energy, and managing oxidative stress. In the context of fasting and ketogenic diets, organic acid testing can help assess the body’s shift from glucose metabolism to fat metabolism. Specific markers, such as beta-hydroxybutyrate and acetoacetate, indicate the presence of ketosis and can be used to monitor the effectiveness of a ketogenic diet .

Additionally, organic acid testing can reveal imbalances in mitochondrial function and oxidative stress, which are relevant to autoimmune conditions. Since both fasting and the ketogenic diet enhance mitochondrial efficiency and reduce oxidative stress, organic acid testing can help determine whether these interventions are supporting overall metabolic health.

Anti-Cardiolipin Blood Marker Serum Analysis

Anti-cardiolipin antibodies are autoantibodies that target cardiolipin, a phospholipid found in the inner mitochondrial membrane. Elevated levels of anti-cardiolipin antibodies are associated with autoimmune diseases, including lupus and other conditions with a significant inflammatory component . Measuring anti-cardiolipin antibodies can provide insights into the autoimmune activity in the body and help determine whether dietary interventions, such as fasting or the ketogenic diet, are reducing autoimmune activity.

In individuals with gut-related autoimmune diseases, elevated anti-cardiolipin antibodies may indicate heightened autoimmune activity and inflammation. Regular monitoring of these markers during fasting or ketogenic dietary interventions can help assess whether the immune system is shifting towards a more regulated, anti-inflammatory state. A reduction in anti-cardiolipin antibody levels may indicate improved immune tolerance and reduced autoimmune activity.

Conclusion

Fasting and ketogenic diets offer promising strategies for reducing Th17 neutrophil-related expression and enhancing Treg activity in individuals with gut-related autoimmune diseases. By modulating the immune system towards a more anti-inflammatory state, these dietary interventions can help reduce chronic inflammation, prevent tissue damage, and improve clinical outcomes.

Fasting reduces inflammatory cytokines that drive Th17 differentiation while increasing Treg activity, creating a more balanced immune response. Similarly, the ketogenic diet reduces inflammation by lowering cytokine production and enhancing Treg function. Together, these interventions offer a novel approach to managing autoimmune diseases.

Monitoring the effectiveness of fasting and ketogenic diets through organic acid testing and anti-cardiolipin blood marker serum analysis is crucial for optimizing these interventions. These tests provide valuable insights into metabolic health and autoimmune activity, helping individuals tailor their dietary strategies for optimal immune modulation and gut health.

References

1. Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009). IL-17 and Th17 Cells. Annual Review of Immunology, 27, 485–517.
2. Michaud, M., & Gorny, A. (2021). Th17 cells in autoimmune disease: Pathogenesis to therapeutic targeting. International Journal of Molecular Sciences, 22(1), 414.
3. Longo, V. D., & Mattson, M. P. (2014). Fasting: Molecular mechanisms and clinical applications. Cell Metabolism, 19(2), 181–192.
4. Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013). Beyond weight loss: A review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. European Journal of Clinical Nutrition, 67(8), 789–796.
5. Youm, Y. H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., … & Dixit, V. D. (2015). The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease. Nature Medicine, 21(3), 263–269.
6. Gregor, M. F., & Hotamisligil, G. S. (2011). Inflammatory mechanisms in obesity. Annual Review of Immunology, 29, 415–445.
7. Roifman, I., Beck, P. L., Anderson, T. J., Eisenberg, M. J., & Genest, J. (2011). Chronic inflammatory diseases and cardiovascular risk: A systematic review. Canadian Journal of Cardiology, 27(2), 174–182.